These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
302 related articles for article (PubMed ID: 23032938)
61. A novel class of selective CK2 inhibitors targeting its open hinge conformation. Dalle Vedove A; Zonta F; Zanforlin E; Demitri N; Ribaudo G; Cazzanelli G; Ongaro A; Sarno S; Zagotto G; Battistutta R; Ruzzene M; Lolli G Eur J Med Chem; 2020 Jun; 195():112267. PubMed ID: 32283296 [TBL] [Abstract][Full Text] [Related]
62. Identification of protein kinase CK2 inhibitors using solvent dipole ordering virtual screening. Nakanishi I; Murata K; Nagata N; Kurono M; Kinoshita T; Yasue M; Miyazaki T; Takei Y; Nakamura S; Sakurai A; Iwamoto N; Nishiwaki K; Nakaniwa T; Sekiguchi Y; Hirasawa A; Tsujimoto G; Kitaura K Eur J Med Chem; 2015; 96():396-404. PubMed ID: 25912672 [TBL] [Abstract][Full Text] [Related]
63. Biochemical characterization of CK2alpha and alpha' paralogues and their derived holoenzymes: evidence for the existence of a heterotrimeric CK2alpha'-holoenzyme forming trimeric complexes. Olsen BB; Rasmussen T; Niefind K; Issinger OG Mol Cell Biochem; 2008 Sep; 316(1-2):37-47. PubMed ID: 18574672 [TBL] [Abstract][Full Text] [Related]
64. Design and synthesis of CK2 inhibitors. Makowska M; Łukowska-Chojnacka E; Wińska P; Kuś A; Bilińska-Chomik A; Bretner M Mol Cell Biochem; 2011 Oct; 356(1-2):91-6. PubMed ID: 21750983 [TBL] [Abstract][Full Text] [Related]
65. Synthesis of novel chiral TBBt derivatives with hydroxyl moiety. Studies on inhibition of human protein kinase CK2α and cytotoxicity properties. Borowiecki P; Wawro AM; Wińska P; Wielechowska M; Bretner M Eur J Med Chem; 2014 Sep; 84():364-74. PubMed ID: 25036794 [TBL] [Abstract][Full Text] [Related]
66. Interaction between CK2α and CK2β, the subunits of protein kinase CK2: thermodynamic contributions of key residues on the CK2α surface. Raaf J; Bischoff N; Klopffleisch K; Brunstein E; Olsen BB; Vilk G; Litchfield DW; Issinger OG; Niefind K Biochemistry; 2011 Feb; 50(4):512-22. PubMed ID: 21142136 [TBL] [Abstract][Full Text] [Related]
67. Eukaryotic translation-initiation factor eIF2beta binds to protein kinase CK2: effects on CK2alpha activity. Llorens F; Roher N; Miró FA; Sarno S; Ruiz FX; Meggio F; Plana M; Pinna LA; Itarte E Biochem J; 2003 Nov; 375(Pt 3):623-31. PubMed ID: 12901717 [TBL] [Abstract][Full Text] [Related]
68. Structural and Mechanistic Basis of the Inhibitory Potency of Selected 2-Aminothiazole Compounds on Protein Kinase CK2. Lindenblatt D; Nickelsen A; Applegate VM; Jose J; Niefind K J Med Chem; 2020 Jul; 63(14):7766-7772. PubMed ID: 32589844 [TBL] [Abstract][Full Text] [Related]
69. Protein kinase CK2 phosphorylates and upregulates Akt/PKB. Di Maira G; Salvi M; Arrigoni G; Marin O; Sarno S; Brustolon F; Pinna LA; Ruzzene M Cell Death Differ; 2005 Jun; 12(6):668-77. PubMed ID: 15818404 [TBL] [Abstract][Full Text] [Related]
70. Biochemical and three-dimensional-structural study of the specific inhibition of protein kinase CK2 by [5-oxo-5,6-dihydroindolo-(1,2-a)quinazolin-7-yl]acetic acid (IQA). Sarno S; de Moliner E; Ruzzene M; Pagano MA; Battistutta R; Bain J; Fabbro D; Schoepfer J; Elliott M; Furet P; Meggio F; Zanotti G; Pinna LA Biochem J; 2003 Sep; 374(Pt 3):639-46. PubMed ID: 12816539 [TBL] [Abstract][Full Text] [Related]
71. Synergistic anti-leukemic effects of CK2 inhibitors and pentabromobenzylisothioureas in vitro. Koronkiewicz M; Chilmonczyk Z; Kazimierczuk Z Anticancer Res; 2013 Nov; 33(11):4891-9. PubMed ID: 24222126 [TBL] [Abstract][Full Text] [Related]
72. First structure of protein kinase CK2 catalytic subunit with an effective CK2β-competitive ligand. Raaf J; Guerra B; Neundorf I; Bopp B; Issinger OG; Jose J; Pietsch M; Niefind K ACS Chem Biol; 2013 May; 8(5):901-7. PubMed ID: 23474121 [TBL] [Abstract][Full Text] [Related]
73. TBBz but not TBBt discriminates between two molecular forms of CK2 in vivo and its implications. Zień P; Abramczyk O; Domańska K; Bretner M; Szyszka R Biochem Biophys Res Commun; 2003 Dec; 312(3):623-8. PubMed ID: 14680810 [TBL] [Abstract][Full Text] [Related]
74. Conformational plasticity of the catalytic subunit of protein kinase CK2 and its consequences for regulation and drug design. Niefind K; Issinger OG Biochim Biophys Acta; 2010 Mar; 1804(3):484-92. PubMed ID: 19796713 [TBL] [Abstract][Full Text] [Related]
75. Selected flavonoid compounds as promising inhibitors of protein kinase CK2α and CK2α', the catalytic subunits of CK2. Baier A; Galicka A; Nazaruk J; Szyszka R Phytochemistry; 2017 Apr; 136():39-45. PubMed ID: 28043654 [TBL] [Abstract][Full Text] [Related]
76. Enzymatic activity with an incomplete catalytic spine: insights from a comparative structural analysis of human CK2α and its paralogous isoform CK2α'. Bischoff N; Raaf J; Olsen B; Bretner M; Issinger OG; Niefind K Mol Cell Biochem; 2011 Oct; 356(1-2):57-65. PubMed ID: 21739153 [TBL] [Abstract][Full Text] [Related]
77. Protein kinase CK2 interacts with adiponectin receptor 1 and participates in adiponectin signaling. Heiker JT; Wottawah CM; Juhl C; Kosel D; Mörl K; Beck-Sickinger AG Cell Signal; 2009 Jun; 21(6):936-42. PubMed ID: 19233263 [TBL] [Abstract][Full Text] [Related]
78. A fragment-based approach leading to the discovery of a novel binding site and the selective CK2 inhibitor CAM4066. De Fusco C; Brear P; Iegre J; Georgiou KH; Sore HF; Hyvönen M; Spring DR Bioorg Med Chem; 2017 Jul; 25(13):3471-3482. PubMed ID: 28495381 [TBL] [Abstract][Full Text] [Related]
79. Discovery and characterization of non-ATP site inhibitors of the mitogen activated protein (MAP) kinases. Comess KM; Sun C; Abad-Zapatero C; Goedken ER; Gum RJ; Borhani DW; Argiriadi M; Groebe DR; Jia Y; Clampit JE; Haasch DL; Smith HT; Wang S; Song D; Coen ML; Cloutier TE; Tang H; Cheng X; Quinn C; Liu B; Xin Z; Liu G; Fry EH; Stoll V; Ng TI; Banach D; Marcotte D; Burns DJ; Calderwood DJ; Hajduk PJ ACS Chem Biol; 2011 Mar; 6(3):234-44. PubMed ID: 21090814 [TBL] [Abstract][Full Text] [Related]
80. Synthesis and evaluation of chemical linchpins for highly selective CK2α targeting. Greco FA; Krämer A; Wahl L; Elson L; Ehret TAL; Gerninghaus J; Möckel J; Müller S; Hanke T; Knapp S Eur J Med Chem; 2024 Oct; 276():116672. PubMed ID: 39067440 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]